COVID-19 Impact on Global Pneumonia Vaccine Market Insights, Forecast to 2026

COVID-19 Impact on Global Pneumonia Vaccine Market Insights, Forecast to 2026

Table of Contents
1 Study Coverage
1.1 Pneumonia Vaccine Product Introduction
1.2 Market Segments
1.3 Key Pneumonia Vaccine Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Pneumonia Vaccine Market Size Growth Rate by Type
1.4.2 Pneumococcal Conjugate Vaccine (PCV13)
1.4.3 Pneumococcal Polysaccharide Vaccine (PPSV23)
1.5 Market by Application
1.5.1 Global Pneumonia Vaccine Market Size Growth Rate by Application
1.5.2 Pneumonia
1.5.3 Meningitis
1.5.4 Sepsis
1.6 Coronavirus Disease 2019 (Covid-19): Pneumonia Vaccine Industry Impact
1.6.1 How the Covid-19 is Affecting the Pneumonia Vaccine Industry
1.6.1.1 Pneumonia Vaccine Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19's Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Pneumonia Vaccine Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Pneumonia Vaccine Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 Executive Summary
2.1 Global Pneumonia Vaccine Market Size Estimates and Forecasts
2.1.1 Global Pneumonia Vaccine Revenue 2015-2026
2.1.2 Global Pneumonia Vaccine Sales 2015-2026
2.2 Pneumonia Vaccine Market Size by Region: 2020 Versus 2026
2.2.1 Global Pneumonia Vaccine Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Pneumonia Vaccine Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Pneumonia Vaccine Competitor Landscape by Players
3.1 Pneumonia Vaccine Sales by Manufacturers
3.1.1 Pneumonia Vaccine Sales by Manufacturers (2015-2020)
3.1.2 Pneumonia Vaccine Sales Market Share by Manufacturers (2015-2020)
3.2 Pneumonia Vaccine Revenue by Manufacturers
3.2.1 Pneumonia Vaccine Revenue by Manufacturers (2015-2020)
3.2.2 Pneumonia Vaccine Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Pneumonia Vaccine Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Pneumonia Vaccine Revenue in 2019
3.2.5 Global Pneumonia Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Pneumonia Vaccine Price by Manufacturers
3.4 Pneumonia Vaccine Manufacturing Base Distribution, Product Types
3.4.1 Pneumonia Vaccine Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Pneumonia Vaccine Product Type
3.4.3 Date of International Manufacturers Enter into Pneumonia Vaccine Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2026)
4.1 Global Pneumonia Vaccine Market Size by Type (2015-2020)
4.1.1 Global Pneumonia Vaccine Sales by Type (2015-2020)
4.1.2 Global Pneumonia Vaccine Revenue by Type (2015-2020)
4.1.3 Pneumonia Vaccine Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Pneumonia Vaccine Market Size Forecast by Type (2021-2026)
4.2.1 Global Pneumonia Vaccine Sales Forecast by Type (2021-2026)
4.2.2 Global Pneumonia Vaccine Revenue Forecast by Type (2021-2026)
4.2.3 Pneumonia Vaccine Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Pneumonia Vaccine Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Breakdown Data by Application (2015-2026)
5.1 Global Pneumonia Vaccine Market Size by Application (2015-2020)
5.1.1 Global Pneumonia Vaccine Sales by Application (2015-2020)
5.1.2 Global Pneumonia Vaccine Revenue by Application (2015-2020)
5.1.3 Pneumonia Vaccine Price by Application (2015-2020)
5.2 Pneumonia Vaccine Market Size Forecast by Application (2021-2026)
5.2.1 Global Pneumonia Vaccine Sales Forecast by Application (2021-2026)
5.2.2 Global Pneumonia Vaccine Revenue Forecast by Application (2021-2026)
5.2.3 Global Pneumonia Vaccine Price Forecast by Application (2021-2026)
6 North America
6.1 North America Pneumonia Vaccine by Country
6.1.1 North America Pneumonia Vaccine Sales by Country
6.1.2 North America Pneumonia Vaccine Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Pneumonia Vaccine Market Facts & Figures by Type
6.3 North America Pneumonia Vaccine Market Facts & Figures by Application
7 Europe
7.1 Europe Pneumonia Vaccine by Country
7.1.1 Europe Pneumonia Vaccine Sales by Country
7.1.2 Europe Pneumonia Vaccine Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Pneumonia Vaccine Market Facts & Figures by Type
7.3 Europe Pneumonia Vaccine Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Pneumonia Vaccine by Region
8.1.1 Asia Pacific Pneumonia Vaccine Sales by Region
8.1.2 Asia Pacific Pneumonia Vaccine Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Pneumonia Vaccine Market Facts & Figures by Type
8.3 Asia Pacific Pneumonia Vaccine Market Facts & Figures by Application
9 Latin America
9.1 Latin America Pneumonia Vaccine by Country
9.1.1 Latin America Pneumonia Vaccine Sales by Country
9.1.2 Latin America Pneumonia Vaccine Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Pneumonia Vaccine Market Facts & Figures by Type
9.3 Central & South America Pneumonia Vaccine Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Pneumonia Vaccine by Country
10.1.1 Middle East and Africa Pneumonia Vaccine Sales by Country
10.1.2 Middle East and Africa Pneumonia Vaccine Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Pneumonia Vaccine Market Facts & Figures by Type
10.3 Middle East and Africa Pneumonia Vaccine Market Facts & Figures by Application
11 Company Profiles
11.1 Pfizer Inc.
11.1.1 Pfizer Inc. Corporation Information
11.1.2 Pfizer Inc. Description, Business Overview and Total Revenue
11.1.3 Pfizer Inc. Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Pfizer Inc. Pneumonia Vaccine Products Offered
11.1.5 Pfizer Inc. Recent Development
11.2 Glaxosmithkline Plc.
11.2.1 Glaxosmithkline Plc. Corporation Information
11.2.2 Glaxosmithkline Plc. Description, Business Overview and Total Revenue
11.2.3 Glaxosmithkline Plc. Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Glaxosmithkline Plc. Pneumonia Vaccine Products Offered
11.2.5 Glaxosmithkline Plc. Recent Development
11.3 Merck & Co., Inc.
11.3.1 Merck & Co., Inc. Corporation Information
11.3.2 Merck & Co., Inc. Description, Business Overview and Total Revenue
11.3.3 Merck & Co., Inc. Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Merck & Co., Inc. Pneumonia Vaccine Products Offered
11.3.5 Merck & Co., Inc. Recent Development
11.4 Sanofi Pasteur
11.4.1 Sanofi Pasteur Corporation Information
11.4.2 Sanofi Pasteur Description, Business Overview and Total Revenue
11.4.3 Sanofi Pasteur Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Sanofi Pasteur Pneumonia Vaccine Products Offered
11.4.5 Sanofi Pasteur Recent Development
11.5 Serum Institute of India Pvt. Ltd.
11.5.1 Serum Institute of India Pvt. Ltd. Corporation Information
11.5.2 Serum Institute of India Pvt. Ltd. Description, Business Overview and Total Revenue
11.5.3 Serum Institute of India Pvt. Ltd. Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Serum Institute of India Pvt. Ltd. Pneumonia Vaccine Products Offered
11.5.5 Serum Institute of India Pvt. Ltd. Recent Development
11.6 Johnson & Johnson
11.6.1 Johnson & Johnson Corporation Information
11.6.2 Johnson & Johnson Description, Business Overview and Total Revenue
11.6.3 Johnson & Johnson Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Johnson & Johnson Pneumonia Vaccine Products Offered
11.6.5 Johnson & Johnson Recent Development
11.7 Astellas Pharma Inc.
11.7.1 Astellas Pharma Inc. Corporation Information
11.7.2 Astellas Pharma Inc. Description, Business Overview and Total Revenue
11.7.3 Astellas Pharma Inc. Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Astellas Pharma Inc. Pneumonia Vaccine Products Offered
11.7.5 Astellas Pharma Inc. Recent Development
11.8 Astrazeneca Plc.
11.8.1 Astrazeneca Plc. Corporation Information
11.8.2 Astrazeneca Plc. Description, Business Overview and Total Revenue
11.8.3 Astrazeneca Plc. Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Astrazeneca Plc. Pneumonia Vaccine Products Offered
11.8.5 Astrazeneca Plc. Recent Development
11.9 CSL Limited
11.9.1 CSL Limited Corporation Information
11.9.2 CSL Limited Description, Business Overview and Total Revenue
11.9.3 CSL Limited Sales, Revenue and Gross Margin (2015-2020)
11.9.4 CSL Limited Pneumonia Vaccine Products Offered
11.9.5 CSL Limited Recent Development
11.10 Emergent Biosolutions
11.10.1 Emergent Biosolutions Corporation Information
11.10.2 Emergent Biosolutions Description, Business Overview and Total Revenue
11.10.3 Emergent Biosolutions Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Emergent Biosolutions Pneumonia Vaccine Products Offered
11.10.5 Emergent Biosolutions Recent Development
11.1 Pfizer Inc.
11.1.1 Pfizer Inc. Corporation Information
11.1.2 Pfizer Inc. Description, Business Overview and Total Revenue
11.1.3 Pfizer Inc. Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Pfizer Inc. Pneumonia Vaccine Products Offered
11.1.5 Pfizer Inc. Recent Development
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Pneumonia Vaccine Market Estimates and Projections by Region
12.1.1 Global Pneumonia Vaccine Sales Forecast by Regions 2021-2026
12.1.2 Global Pneumonia Vaccine Revenue Forecast by Regions 2021-2026
12.2 North America Pneumonia Vaccine Market Size Forecast (2021-2026)
12.2.1 North America: Pneumonia Vaccine Sales Forecast (2021-2026)
12.2.2 North America: Pneumonia Vaccine Revenue Forecast (2021-2026)
12.2.3 North America: Pneumonia Vaccine Market Size Forecast by Country (2021-2026)
12.3 Europe Pneumonia Vaccine Market Size Forecast (2021-2026)
12.3.1 Europe: Pneumonia Vaccine Sales Forecast (2021-2026)
12.3.2 Europe: Pneumonia Vaccine Revenue Forecast (2021-2026)
12.3.3 Europe: Pneumonia Vaccine Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Pneumonia Vaccine Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Pneumonia Vaccine Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Pneumonia Vaccine Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Pneumonia Vaccine Market Size Forecast by Region (2021-2026)
12.5 Latin America Pneumonia Vaccine Market Size Forecast (2021-2026)
12.5.1 Latin America: Pneumonia Vaccine Sales Forecast (2021-2026)
12.5.2 Latin America: Pneumonia Vaccine Revenue Forecast (2021-2026)
12.5.3 Latin America: Pneumonia Vaccine Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Pneumonia Vaccine Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Pneumonia Vaccine Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Pneumonia Vaccine Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Pneumonia Vaccine Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter's Five Forces Analysis
13.5 Primary Interviews with Key Pneumonia Vaccine Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Pneumonia Vaccine Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
List of Tables
Table 1. Pneumonia Vaccine Market Segments
Table 2. Ranking of Global Top Pneumonia Vaccine Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Pneumonia Vaccine Market Size Growth Rate by Type 2020-2026 (K Doses) & (US$ Million)
Table 4. Major Manufacturers of Pneumococcal Conjugate Vaccine (PCV13)
Table 5. Major Manufacturers of Pneumococcal Polysaccharide Vaccine (PPSV23)
Table 6. COVID-19 Impact Global Market: (Four Pneumonia Vaccine Market Size Forecast Scenarios)
Table 7. Opportunities and Trends for Pneumonia Vaccine Players in the COVID-19 Landscape
Table 8. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 9. Key Regions/Countries Measures against Covid-19 Impact
Table 10. Proposal for Pneumonia Vaccine Players to Combat Covid-19 Impact
Table 11. Global Pneumonia Vaccine Market Size Growth Rate by Application 2020-2026 (K Doses)
Table 12. Global Pneumonia Vaccine Market Size by Region (K Doses) & (US$ Million): 2020 VS 2026
Table 13. Global Pneumonia Vaccine Sales by Regions 2015-2020 (K Doses)
Table 14. Global Pneumonia Vaccine Sales Market Share by Regions (2015-2020)
Table 15. Global Pneumonia Vaccine Revenue by Regions 2015-2020 (US$ Million)
Table 16. Global Pneumonia Vaccine Sales by Manufacturers (2015-2020) (K Doses)
Table 17. Global Pneumonia Vaccine Sales Share by Manufacturers (2015-2020)
Table 18. Global Pneumonia Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 19. Global Pneumonia Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pneumonia Vaccine as of 2019)
Table 20. Pneumonia Vaccine Revenue by Manufacturers (2015-2020) (US$ Million)
Table 21. Pneumonia Vaccine Revenue Share by Manufacturers (2015-2020)
Table 22. Key Manufacturers Pneumonia Vaccine Price (2015-2020) (USD/Dose)
Table 23. Pneumonia Vaccine Manufacturers Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers Pneumonia Vaccine Product Type
Table 25. Date of International Manufacturers Enter into Pneumonia Vaccine Market
Table 26. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 27. Global Pneumonia Vaccine Sales by Type (2015-2020) (K Doses)
Table 28. Global Pneumonia Vaccine Sales Share by Type (2015-2020)
Table 29. Global Pneumonia Vaccine Revenue by Type (2015-2020) (US$ Million)
Table 30. Global Pneumonia Vaccine Revenue Share by Type (2015-2020)
Table 31. Pneumonia Vaccine Average Selling Price (ASP) by Type 2015-2020 (USD/Dose)
Table 32. Global Pneumonia Vaccine Sales by Application (2015-2020) (K Doses)
Table 33. Global Pneumonia Vaccine Sales Share by Application (2015-2020)
Table 34. North America Pneumonia Vaccine Sales by Country (2015-2020) (K Doses)
Table 35. North America Pneumonia Vaccine Sales Market Share by Country (2015-2020)
Table 36. North America Pneumonia Vaccine Revenue by Country (2015-2020) (US$ Million)
Table 37. North America Pneumonia Vaccine Revenue Market Share by Country (2015-2020)
Table 38. North America Pneumonia Vaccine Sales by Type (2015-2020) (K Doses)
Table 39. North America Pneumonia Vaccine Sales Market Share by Type (2015-2020)
Table 40. North America Pneumonia Vaccine Sales by Application (2015-2020) (K Doses)
Table 41. North America Pneumonia Vaccine Sales Market Share by Application (2015-2020)
Table 42. Europe Pneumonia Vaccine Sales by Country (2015-2020) (K Doses)
Table 43. Europe Pneumonia Vaccine Sales Market Share by Country (2015-2020)
Table 44. Europe Pneumonia Vaccine Revenue by Country (2015-2020) (US$ Million)
Table 45. Europe Pneumonia Vaccine Revenue Market Share by Country (2015-2020)
Table 46. Europe Pneumonia Vaccine Sales by Type (2015-2020) (K Doses)
Table 47. Europe Pneumonia Vaccine Sales Market Share by Type (2015-2020)
Table 48. Europe Pneumonia Vaccine Sales by Application (2015-2020) (K Doses)
Table 49. Europe Pneumonia Vaccine Sales Market Share by Application (2015-2020)
Table 50. Asia Pacific Pneumonia Vaccine Sales by Region (2015-2020) (K Doses)
Table 51. Asia Pacific Pneumonia Vaccine Sales Market Share by Region (2015-2020)
Table 52. Asia Pacific Pneumonia Vaccine Revenue by Region (2015-2020) (US$ Million)
Table 53. Asia Pacific Pneumonia Vaccine Revenue Market Share by Region (2015-2020)
Table 54. Asia Pacific Pneumonia Vaccine Sales by Type (2015-2020) (K Doses)
Table 55. Asia Pacific Pneumonia Vaccine Sales Market Share by Type (2015-2020)
Table 56. Asia Pacific Pneumonia Vaccine Sales by Application (2015-2020) (K Doses)
Table 57. Asia Pacific Pneumonia Vaccine Sales Market Share by Application (2015-2020)
Table 58. Latin America Pneumonia Vaccine Sales by Country (2015-2020) (K Doses)
Table 59. Latin America Pneumonia Vaccine Sales Market Share by Country (2015-2020)
Table 60. Latin Americaa Pneumonia Vaccine Revenue by Country (2015-2020) (US$ Million)
Table 61. Latin America Pneumonia Vaccine Revenue Market Share by Country (2015-2020)
Table 62. Latin America Pneumonia Vaccine Sales by Type (2015-2020) (K Doses)
Table 63. Latin America Pneumonia Vaccine Sales Market Share by Type (2015-2020)
Table 64. Latin America Pneumonia Vaccine Sales by Application (2015-2020) (K Doses)
Table 65. Latin America Pneumonia Vaccine Sales Market Share by Application (2015-2020)
Table 66. Middle East and Africa Pneumonia Vaccine Sales by Country (2015-2020) (K Doses)
Table 67. Middle East and Africa Pneumonia Vaccine Sales Market Share by Country (2015-2020)
Table 68. Middle East and Africa Pneumonia Vaccine Revenue by Country (2015-2020) (US$ Million)
Table 69. Middle East and Africa Pneumonia Vaccine Revenue Market Share by Country (2015-2020)
Table 70. Middle East and Africa Pneumonia Vaccine Sales by Type (2015-2020) (K Doses)
Table 71. Middle East and Africa Pneumonia Vaccine Sales Market Share by Type (2015-2020)
Table 72. Middle East and Africa Pneumonia Vaccine Sales by Application (2015-2020) (K Doses)
Table 73. Middle East and Africa Pneumonia Vaccine Sales Market Share by Application (2015-2020)
Table 74. Pfizer Inc. Corporation Information
Table 75. Pfizer Inc. Description and Major Businesses
Table 76. Pfizer Inc. Pneumonia Vaccine Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 77. Pfizer Inc. Product
Table 78. Pfizer Inc. Recent Development
Table 79. Glaxosmithkline Plc. Corporation Information
Table 80. Glaxosmithkline Plc. Description and Major Businesses
Table 81. Glaxosmithkline Plc. Pneumonia Vaccine Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 82. Glaxosmithkline Plc. Product
Table 83. Glaxosmithkline Plc. Recent Development
Table 84. Merck & Co., Inc. Corporation Information
Table 85. Merck & Co., Inc. Description and Major Businesses
Table 86. Merck & Co., Inc. Pneumonia Vaccine Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 87. Merck & Co., Inc. Product
Table 88. Merck & Co., Inc. Recent Development
Table 89. Sanofi Pasteur Corporation Information
Table 90. Sanofi Pasteur Description and Major Businesses
Table 91. Sanofi Pasteur Pneumonia Vaccine Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 92. Sanofi Pasteur Product
Table 93. Sanofi Pasteur Recent Development
Table 94. Serum Institute of India Pvt. Ltd. Corporation Information
Table 95. Serum Institute of India Pvt. Ltd. Description and Major Businesses
Table 96. Serum Institute of India Pvt. Ltd. Pneumonia Vaccine Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 97. Serum Institute of India Pvt. Ltd. Product
Table 98. Serum Institute of India Pvt. Ltd. Recent Development
Table 99. Johnson & Johnson Corporation Information
Table 100. Johnson & Johnson Description and Major Businesses
Table 101. Johnson & Johnson Pneumonia Vaccine Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 102. Johnson & Johnson Product
Table 103. Johnson & Johnson Recent Development
Table 104. Astellas Pharma Inc. Corporation Information
Table 105. Astellas Pharma Inc. Description and Major Businesses
Table 106. Astellas Pharma Inc. Pneumonia Vaccine Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 107. Astellas Pharma Inc. Product
Table 108. Astellas Pharma Inc. Recent Development
Table 109. Astrazeneca Plc. Corporation Information
Table 110. Astrazeneca Plc. Description and Major Businesses
Table 111. Astrazeneca Plc. Pneumonia Vaccine Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 112. Astrazeneca Plc. Product
Table 113. Astrazeneca Plc. Recent Development
Table 114. CSL Limited Corporation Information
Table 115. CSL Limited Description and Major Businesses
Table 116. CSL Limited Pneumonia Vaccine Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 117. CSL Limited Product
Table 118. CSL Limited Recent Development
Table 119. Emergent Biosolutions Corporation Information
Table 120. Emergent Biosolutions Description and Major Businesses
Table 121. Emergent Biosolutions Pneumonia Vaccine Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 122. Emergent Biosolutions Product
Table 123. Emergent Biosolutions Recent Development
Table 124. Global Pneumonia Vaccine Sales Forecast by Regions (2021-2026) (K Doses)
Table 125. Global Pneumonia Vaccine Sales Market Share Forecast by Regions (2021-2026)
Table 126. Global Pneumonia Vaccine Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 127. Global Pneumonia Vaccine Revenue Market Share Forecast by Regions (2021-2026)
Table 128. North America: Pneumonia Vaccine Sales Forecast by Country (2021-2026) (K Doses)
Table 129. North America: Pneumonia Vaccine Revenue Forecast by Country (2021-2026) (US$ Million)
Table 130. Europe: Pneumonia Vaccine Sales Forecast by Country (2021-2026) (K Doses)
Table 131. Europe: Pneumonia Vaccine Revenue Forecast by Country (2021-2026) (US$ Million)
Table 132. Asia Pacific: Pneumonia Vaccine Sales Forecast by Region (2021-2026) (K Doses)
Table 133. Asia Pacific: Pneumonia Vaccine Revenue Forecast by Region (2021-2026) (US$ Million)
Table 134. Latin America: Pneumonia Vaccine Sales Forecast by Country (2021-2026) (K Doses)
Table 135. Latin America: Pneumonia Vaccine Revenue Forecast by Country (2021-2026) (US$ Million)
Table 136. Middle East and Africa: Pneumonia Vaccine Sales Forecast by Country (2021-2026) (K Doses)
Table 137. Middle East and Africa: Pneumonia Vaccine Revenue Forecast by Country (2021-2026) (US$ Million)
Table 138. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 139. Key Challenges
Table 140. Market Risks
Table 141. Main Points Interviewed from Key Pneumonia Vaccine Players
Table 142. Pneumonia Vaccine Customers List
Table 143. Pneumonia Vaccine Distributors List
Table 144. Research Programs/Design for This Report
Table 145. Key Data Information from Secondary Sources
Table 146. Key Data Information from Primary Sources
List of Figures
Figure 1. Pneumonia Vaccine Product Picture
Figure 2. Global Pneumonia Vaccine Sales Market Share by Type in 2020 & 2026
Figure 3. Pneumococcal Conjugate Vaccine (PCV13) Product Picture
Figure 4. Pneumococcal Polysaccharide Vaccine (PPSV23) Product Picture
Figure 5. Global Pneumonia Vaccine Sales Market Share by Application in 2020 & 2026
Figure 6. Pneumonia
Figure 7. Meningitis
Figure 8. Sepsis
Figure 9. Pneumonia Vaccine Report Years Considered
Figure 10. Global Pneumonia Vaccine Market Size 2015-2026 (US$ Million)
Figure 11. Global Pneumonia Vaccine Sales 2015-2026 (K Doses)
Figure 12. Global Pneumonia Vaccine Market Size Market Share by Region: 2020 Versus 2026
Figure 13. Global Pneumonia Vaccine Sales Market Share by Region (2015-2020)
Figure 14. Global Pneumonia Vaccine Sales Market Share by Region in 2019
Figure 15. Global Pneumonia Vaccine Revenue Market Share by Region (2015-2020)
Figure 16. Global Pneumonia Vaccine Revenue Market Share by Region in 2019
Figure 17. Global Pneumonia Vaccine Sales Share by Manufacturer in 2019
Figure 18. The Top 10 and 5 Players Market Share by Pneumonia Vaccine Revenue in 2019
Figure 19. Pneumonia Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 20. Global Pneumonia Vaccine Sales Market Share by Type (2015-2020)
Figure 21. Global Pneumonia Vaccine Sales Market Share by Type in 2019
Figure 22. Global Pneumonia Vaccine Revenue Market Share by Type (2015-2020)
Figure 23. Global Pneumonia Vaccine Revenue Market Share by Type in 2019
Figure 24. Global Pneumonia Vaccine Market Share by Price Range (2015-2020)
Figure 25. Global Pneumonia Vaccine Sales Market Share by Application (2015-2020)
Figure 26. Global Pneumonia Vaccine Sales Market Share by Application in 2019
Figure 27. Global Pneumonia Vaccine Revenue Market Share by Application (2015-2020)
Figure 28. Global Pneumonia Vaccine Revenue Market Share by Application in 2019
Figure 29. North America Pneumonia Vaccine Sales Growth Rate 2015-2020 (K Doses)
Figure 30. North America Pneumonia Vaccine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 31. North America Pneumonia Vaccine Sales Market Share by Country in 2019
Figure 32. North America Pneumonia Vaccine Revenue Market Share by Country in 2019
Figure 33. U.S. Pneumonia Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 34. U.S. Pneumonia Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 35. Canada Pneumonia Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 36. Canada Pneumonia Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. North America Pneumonia Vaccine Market Share by Type in 2019
Figure 38. North America Pneumonia Vaccine Market Share by Application in 2019
Figure 39. Europe Pneumonia Vaccine Sales Growth Rate 2015-2020 (K Doses)
Figure 40. Europe Pneumonia Vaccine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 41. Europe Pneumonia Vaccine Sales Market Share by Country in 2019
Figure 42. Europe Pneumonia Vaccine Revenue Market Share by Country in 2019
Figure 43. Germany Pneumonia Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 44. Germany Pneumonia Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 45. France Pneumonia Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 46. France Pneumonia Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. U.K. Pneumonia Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 48. U.K. Pneumonia Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. Italy Pneumonia Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 50. Italy Pneumonia Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Russia Pneumonia Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 52. Russia Pneumonia Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Europe Pneumonia Vaccine Market Share by Type in 2019
Figure 54. Europe Pneumonia Vaccine Market Share by Application in 2019
Figure 55. Asia Pacific Pneumonia Vaccine Sales Growth Rate 2015-2020 (K Doses)
Figure 56. Asia Pacific Pneumonia Vaccine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 57. Asia Pacific Pneumonia Vaccine Sales Market Share by Region in 2019
Figure 58. Asia Pacific Pneumonia Vaccine Revenue Market Share by Region in 2019
Figure 59. China Pneumonia Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 60. China Pneumonia Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 61. Japan Pneumonia Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 62. Japan Pneumonia Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. South Korea Pneumonia Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 64. South Korea Pneumonia Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. India Pneumonia Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 66. India Pneumonia Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. Australia Pneumonia Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 68. Australia Pneumonia Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Taiwan Pneumonia Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 70. Taiwan Pneumonia Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Indonesia Pneumonia Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 72. Indonesia Pneumonia Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Thailand Pneumonia Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 74. Thailand Pneumonia Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Malaysia Pneumonia Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 76. Malaysia Pneumonia Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Philippines Pneumonia Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 78. Philippines Pneumonia Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Vietnam Pneumonia Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 80. Vietnam Pneumonia Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Asia Pacific Pneumonia Vaccine Market Share by Type in 2019
Figure 82. Asia Pacific Pneumonia Vaccine Market Share by Application in 2019
Figure 83. Latin America Pneumonia Vaccine Sales Growth Rate 2015-2020 (K Doses)
Figure 84. Latin America Pneumonia Vaccine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 85. Latin America Pneumonia Vaccine Sales Market Share by Country in 2019
Figure 86. Latin America Pneumonia Vaccine Revenue Market Share by Country in 2019
Figure 87. Mexico Pneumonia Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 88. Mexico Pneumonia Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 89. Brazil Pneumonia Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 90. Brazil Pneumonia Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 91. Argentina Pneumonia Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 92. Argentina Pneumonia Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Latin America Pneumonia Vaccine Market Share by Type in 2019
Figure 94. Latin America Pneumonia Vaccine Market Share by Application in 2019
Figure 95. Middle East and Africa Pneumonia Vaccine Sales Growth Rate 2015-2020 (K Doses)
Figure 96. Middle East and Africa Pneumonia Vaccine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 97. Middle East and Africa Pneumonia Vaccine Sales Market Share by Country in 2019
Figure 98. Middle East and Africa Pneumonia Vaccine Revenue Market Share by Country in 2019
Figure 99. Turkey Pneumonia Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 100. Turkey Pneumonia Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 101. Saudi Arabia Pneumonia Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 102. Saudi Arabia Pneumonia Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 103. U.A.E Pneumonia Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 104. U.A.E Pneumonia Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. Middle East and Africa Pneumonia Vaccine Market Share by Type in 2019
Figure 106. Middle East and Africa Pneumonia Vaccine Market Share by Application in 2019
Figure 107. Pfizer Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 108. Glaxosmithkline Plc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 109. Merck & Co., Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 110. Sanofi Pasteur Total Revenue (US$ Million): 2019 Compared with 2018
Figure 111. Serum Institute of India Pvt. Ltd. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 112. Johnson & Johnson Total Revenue (US$ Million): 2019 Compared with 2018
Figure 113. Astellas Pharma Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 114. Astrazeneca Plc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 115. CSL Limited Total Revenue (US$ Million): 2019 Compared with 2018
Figure 116. Emergent Biosolutions Total Revenue (US$ Million): 2019 Compared with 2018
Figure 117. North America Pneumonia Vaccine Sales Growth Rate Forecast (2021-2026) (K Doses)
Figure 118. North America Pneumonia Vaccine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 119. Europe Pneumonia Vaccine Sales Growth Rate Forecast (2021-2026) (K Doses)
Figure 120. Europe Pneumonia Vaccine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Histone Deacetylase (HDAC) Inhibitors Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 87

The global Histone Deacetylase (HDAC) Inhibitors market was valued at US$ 615.2 million in 2023 and is anticipated to reach US$ 1223.2 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030. North American market for Histone Deacetylase (HDAC) Inhibitors is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Histone Deacetylase (HDAC) Inhibitor......

Global Esomeprazole Magnesium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 74

The global Esomeprazole Magnesium market was valued at US$ 5287 million in 2023 and is anticipated to reach US$ 9451.5 million by 2030, witnessing a CAGR of 8.3% during The forecast period 2024-2030. North American market for Esomeprazole Magnesium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Esomeprazole Magnesium is estimated to increase from $ million in 2......

Global Combination Therapy Drug Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Combination Therapy Drug market was valued at US$ 105 million in 2023 and is anticipated to reach US$ 166.7 million by 2030, witnessing a CAGR of 4.1% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is......

Global Axitinib Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 68

The global Axitinib market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The......

Global Lyme Disease Vaccine Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 70

The lyme disease vaccine can reduce lyme disease incidence, reduce symptoms and reduce mortality. Lyme disease is a tick-borne infection of spirochete, a natural disease caused by borrelia burgdorferi. The global Lyme Disease Vaccine market was valued at US$ 257 million in 2023 and is anticipated to reach US$ 763 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at......

Global Transdermal Absorption Patch Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Transdermal Absorption Patch market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Transdermal Absorption Patch is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Transdermal Absorption Patch is estimated to increase from $ million i......

Global Ketoprofen Patches Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

Ketoprofen patch, indications for The treatment of symptoms caused by The following diseases: rheumatoid arthritis and rheumatoid arthritis The global Ketoprofen Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Ketoprofen Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast per......

Global Methyl Salicylate Patches Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 82

The global Methyl Salicylate Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to......

Global Diclofenac Patches Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Diclofenac Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs